T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.79B |
| 2 |
PayPal
PYPL
|
+$1.64B |
| 3 |
Alibaba
BABA
|
+$1.46B |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$1.11B |
| 5 |
Johnson Controls International
JCI
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$8.15B |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$1.77B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.74B |
| 4 |
Danaher
DHR
|
+$1.54B |
| 5 |
GE Aerospace
GE
|
+$1.26B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.56% |
| 2 | Consumer Discretionary | 15.28% |
| 3 | Financials | 14.93% |
| 4 | Technology | 13.43% |
| 5 | Communication Services | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Corvus Pharmaceuticals
CRVS
$1.27B
| $10.5M | ﹤0.01% |
638,297
+3,409
| +0.5% | +$49.1K |
|
|
BPMC
1302
DELISTED
Blueprint Medicines
BPMC
| $10.5M | ﹤0.01% |
353,194
-241,789
| -41% | -$6.01M |
|
|
INVN
1303
DELISTED
Invensense Inc
INVN
| $10.4M | ﹤0.01% |
1,408,360
+3,700
| +0.3% | +$26.2K |
|
|
SNI
1304
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $10.4M | ﹤0.01% |
163,650
+910
| +0.6% | +$58.2K |
|
|
SFLY
1305
DELISTED
Shutterfly, Inc.
SFLY
| $10.3M | ﹤0.01% |
231,300
+28,900
| +14% | +$1.43M |
|
|
OXFD
1306
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $10.2M | ﹤0.01% |
812,927
-288
| -0% | -$2.89K |
|
1307
Wingstop
WING
$3.1B
| $10.2M | ﹤0.01% |
347,329
+93,070
| +37% | +$2.69M |
|
|
KATE
1308
DELISTED
Kate Spade & Company
KATE
| $10.2M | ﹤0.01% |
593,024
-119,439
| -17% | -$2.32M |
|
1309
H&R Block
HRB
$6.76B
| $10.1M | ﹤0.01% |
438,418
+1,010
| +0.2% | +$23.6K |
|
1310
Comscore
SCOR
$91.6M
| $10.1M | ﹤0.01% |
16,464
+980
| +6% | +$556K |
|
|
TAHO
1311
DELISTED
Tahoe Resources Inc
TAHO
| $10.1M | ﹤0.01% |
788,673
-785,005
| -50% | -$11.6M |
|
1312
Williams-Sonoma
WSM
$28.5B
| $10.1M | ﹤0.01% |
394,626
-1,520
| -0.4% | -$39.8K |
|
1313
Opko Health
OPK
$1.04B
| $10M | ﹤0.01% |
947,871
+28,700
| +3% | +$286K |
|
|
BOLD
1314
DELISTED
Audentes Therapeutics, Inc
BOLD
| $10M | ﹤0.01% |
+579,681
| New | +$8.8M |
|
|
RAD
1315
DELISTED
Rite Aid Corporation
RAD
| $10M | ﹤0.01% |
65,188
-566,944
| -90% | -$84.6M |
|
1316
Ingevity
NGVT
$2.59B
| $9.93M | ﹤0.01% |
215,360
-183,316
| -46% | -$7.74M |
|
1317
e.l.f. Beauty
ELF
$5.43B
| $9.85M | ﹤0.01% |
+350,110
| New | +$9.16M |
|
1318
Boot Barn
BOOT
$4.92B
| $9.82M | ﹤0.01% |
863,337
+778,267
| +915% | +$8.36M |
|
|
GRMN
1319
Garmin
GRMN
$60.2B
| $9.81M | ﹤0.01% |
203,990
-200
| -0.1% | -$9.87K |
|
|
ABAX
1320
DELISTED
Abaxis Inc
ABAX
| $9.75M | ﹤0.01% |
188,860
+16,900
| +10% | +$847K |
|
1321
NETSCOUT
NTCT
$2.89B
| $9.73M | ﹤0.01% |
332,765
+15,165
| +5% | +$416K |
|
1322
Standex International
SXI
$3.97B
| $9.68M | ﹤0.01% |
104,235
+6,005
| +6% | +$526K |
|
1323
Integer Holdings
ITGR
$4.25B
| $9.56M | ﹤0.01% |
440,950
+430,130
| +3,975% | +$11M |
|
|
ALDR
1324
DELISTED
Alder Biopharmaceuticals
ALDR
| $9.52M | ﹤0.01% |
+290,446
| New | +$8.85M |
|
1325
Seres Therapeutics
MCRB
$45M
| $9.26M | ﹤0.01% |
37,674
-19,705
| -34% | -$6.91M |
|
Similar funds
T. Rowe Price Associates's Q3 2016 Portfolio in Review
As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
- T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
- T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
- T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
- T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
- T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
- T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.
Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.